JPRN-UMIN000025065
Recruiting
未知
Phase II clinical trial for the effectiveness and safety of AW-PD01 (helium / oxygen mixed gas) for respiratory failure in children and infants with airway stenotic lesions: Single facility single group open label intervention study - Helium-Oxygen gas clinical trial for infant with obstructive airway disease
Tokyo Metropolitan Children's Medical Center0 sites10 target enrollmentDecember 1, 2016
ConditionsRespiratory failure, Bronchiolitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Respiratory failure, Bronchiolitis
- Sponsor
- Tokyo Metropolitan Children's Medical Center
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. With cyanotic heart disease 2\. With chronic lung disease 3\. Receiving a diagnosis of bronchial asthma 4\. patients who are judged unsuitable as subjects of the examination by the attending doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Phase II clinical trial to evaluate the efficacy and safety in the use of pancreatic islets cells from cadaver donors for the treatment of Type-I Diabetes Mellitus in renal transplant patients.Type-I Diabetes Mellitus in renal trasplant patientsMedDRA version: 8.1Level: ptClassification code 10061835EUCTR2005-004523-19-ESÁrea de Trasplante y Terapia Celular - Hospital Central de Asturias10
Active, not recruiting
Phase 1
Phase III clinical trial to evaluate the efficacy and safety of inhaled ethanol in the treatment of early-stage COVID-19.COVID-19Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-001760-29-ESSociedad Española de Farmacia Hospitalaria156
Active, not recruiting
Phase 1
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-000810-44-ESFundació Sant Joan de Déu30
Completed
Phase 2
Phase 2 clinical trial evaluating the efficacy and safety of ART-001 in patients with slow-flow vascular malformationsSlow flow vascular malformationsJPRN-jRCT2071210027agabukuro Hiroshi34
Completed
Phase 2
Phase 2 clinical trial evaluating the efficacy and safety of ART-648 in patients with bullous pemphigoidMild to moderate bullous pemphigoidJPRN-jRCT2071210034agabukuro Hiroshi30